7 news items
Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch
PTPI
29 May 24
Study paves the way toward a first-ever innovation program to include AI-optimization for FDA-guided Rx-to-OTC switch
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
PTPI
21 May 24
of becoming a leading innovator in the emerging self-care market driving expanded access to key prescription pharmaceuticals as Over-the-Counter
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
ME
PTPI
14 May 24
is committed to the goal of becoming a leading innovator in the emerging self-care market driving expanded access to key prescription pharmaceuticals as Over
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
PTPI
25 Apr 24
to leveraging innovative solutions to improve patient access to essential medications and streamline healthcare delivery processes.Contact
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
PTPI
23 Apr 24
innovator in the emerging self-care market driving expanded access to key prescription pharmaceuticals as Over-the-Counter treatment options. Currently
iyy866hi99i1n765zjaav 1esadtzi5rhdbi
PTPI
16 Apr 24
expand OTC access to medications that formerly could only be available by prescription. An ACNU may be an innovative computerized tool, or the additional conditions may use other approaches that support the switch process.
abnhhitubdfj81my8 eb2np5n6ehgzdvs4
PTPI
16 Apr 24
be an innovative computerized tool, or the additional conditions may use other approaches that support the switch process.About Petros
- Prev
- 1
- Next